Option chain shows key data for Sonoma Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sonoma Pharmaceuticals.

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock, Option Chain

Sonoma Pharmaceuticals

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

News

Stock Split

SNOA

Sonoma Pharmaceuticals shares are trading lower by 7.8% Wednesday morning. The company announced a 1-for-20 reverse stock split.

Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving

movers image

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADAP

AILE

AIMD

ANTE

CMAX

ESPR

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

HUMA

LGMK

MMAT

NDRA

PSIG

TNON

YMAB

Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket

Intraday Update

APLD

ATPC

AVAH

CRWD

DOGZ

EMBC

FTEL

KARO

LGCB

LPSN

MEDS

MEIP

MIRA

MNSO

NCPL

NUKK

NWGL

PRTG

RYAAY

SAVA

SERV

SLNA

SLRX

SOPA

TELL

TKNO

VIRI

XCUR

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals Inc

Press Releases

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Events

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Contracts

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Earnings

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Legal

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Akanda

Artelo Biosciences

Avenue Therapeutics

Aytu BioPharma

Biofrontera

CNS Pharma

China Pharma Holding

Enveric Biosciences

Evoke Pharma

Eyenovia

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharma

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharma

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

SenesTech

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

Talphera

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

Virpax Pharmaceuticals, Inc. - Common Stock

Virpax Pharmaceuticals

cbdMD

Ladenburg Thalmann

Comments

Sonoma Pharmaceuticals

Sonoma Pharmaceuticals (SNOA) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga